Spruce Biosciences Inc expected to post a loss of 46  cents a share - Earnings Preview

Spruce Biosciences

06/05/2022 17:11

* Spruce Biosciences Inc  SPRB.OQ   SPRB.O  is expected
to show no
change in quarterly revenue when it reports  results on May 10
(estimated). 
    * ​Refinitiv's mean analyst estimate for Spruce Biosciences
Inc is
for a loss of 46 cents per share. For the same quarter last
year, the company reported a loss of 42 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 1.5%
in the last three months. ​
    * Wall Street's median 12-month price target for Spruce
Biosciences Inc is $7.5​, above​ its last closing price
of $1.67. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.54       -0.54      -0.39     Beat    27.8
 Sep. 30 2021  -0.58       -0.57      -0.49     Beat    14.4
 Jun. 30 2021  -0.45       -0.45      -0.50     Missed  -11.1​
 Mar. 31 2021  -0.42       -0.42      -0.42     Met     0.8
 ​​Dec.                    -0.59      -0.39     Beat    34.4
 31 2020                                                
 Sep. 30 2020  -0.51       -0.51      -12.35    Missed  -2,321
                                                        .6​
 This summary was machine generated May 6 at 16:11 GMT.  All
figures in US dollars  unless otherwise stated